Everolimus

From Medicine GPT
Revision as of 05:08, 9 January 2023 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Everolimus
TermEverolimus
Short definitionevent-free survival (eh-VENT … ser-VY-vul) In cancer, the length of time after initial treatment for a cancer is until the patient remains free of specified complications or events that require treatment should prevent or delay. These events may include the cancer coming back or the appearance of certain symptoms, such as B. 
TypeCancer terms
SpecialtyOncology
LanguageEnglish
SourceNCI
Comments


Everolimus - (pronounced) (eh-veh-ROH-lih-mus) A drug used alone or with other drugs to treat certain types of breast cancer, kidney cancer, and neuroendocrine tumors of the pancreas, lungs, and gastrointestinal tract gastrointestinal tract is used. It is used under the brand name Afinitor to treat these types of cancer and to treat a type of benign kidney tumor called renal angiomyolipoma and a type of benign brain tumor called subependymal giant cell astrocytoma in patients with tuberous sclerosis. Everolimus is also used under the brand name Afinitor Disperz to treat subependymal giant cell astrocytoma and certain types of seizures in patients with tuberous sclerosis. It is also used under the brand name Zortress to prevent the body from rejecting a kidney or liver transplant. Everolimus is also being studied to treat other diseases and cancers. It blocks a protein involved in cell division, which can help prevent abnormal cells, including cancer cells, from growing. It can also prevent the growth of new blood vessels that tumors need to grow. Everolimus also lowers the body's immune response. It's a type of kinase inhibitor, a type of angiogenesis inhibitor, and a type of immunosuppressant. Also called RAD001

External links

Esculaap.svg

This MedicineGPT article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski